The healthcare advocacy group Community Catalyst has begun what it says is the first comprehensive campaign to conduct and publicize research on potential conflicts of interest arising from the $12 billion spent annually on pharmaceutical marketing directed at physicians.
The Centers for Medicare & Medicaid Services (CMS) must strengthen its guidance regarding an exception to Medicaid price-reporting requirements to prevent drug companies' abuse of that provision, key lawmakers say.
An HIV/AIDS healthcare provider has filed a lawsuit against Pfizer, saying its marketing campaign for Viagra promoted recreational use of the drug and contributed to increased incidence of sexually transmitted diseases (STDs), including HIV.
An analysis of 84 studies by HHS' Agency for Healthcare Research and Quality (AHRQ) found no strong evidence that atypical antipsychotics are effective for many of the off-label uses for which they are commonly prescribed.
The "art and science" of branding -- developing name and image recognition for a particular product and company -- is still in the developmental stages in the device industry, according to Nancy Turett, president of the health division at the public relations firm Edelman.
Medtronic has launched a national print, television and online advertising campaign to raise awareness of sudden cardiac arrest (SCA), its risk factors and the role of implantable cardioverter-defibrillator (ICD) therapy, the firm said Jan. 15.
Improved drug safety is foremost in the FDA's Prescription Drug User Fee Act (PDUFA) proposal that seeks new authority and more than $29 million in additional fees specifically to improve its postmarket safety surveillance.